Story thread · 3 reports / 1 sources
KFF: Who wins under CMS’ 340B proposal?
beckershospitalreview.com · 12d
How the coverage leans
Across 1 sources · syndicated copies counted once
The 340B Drug Pricing Program has faced mounting legal pressure throughout 2026, including Eli Lilly’s enforcement of a claims-data requirement that has left roughly 1,000 noncompliant covered entities exposed to suspended 340B pricing, and CVS’s motions to dismiss lawsuits from hospital systems alleging the company diverted hundreds of millions in 340B savings. Now CMS is […] The post KFF: Who wins under CMS’ 340B proposal? appeared first on Becker's Hospital Review | Healthcare News & Analysis .
First report: CVS looks to dismiss hospitals’ 340B lawsuits — beckershospitalreview.com, 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.